Pancreatic Cancer Research

ResearcherUniversity of BonnNo recent work listed

Gunther Hartmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1021-2018; OpenAlex author ID A5070273513. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. Targeted Nanoparticle Delivery of Bifunctional RIG-I Agonists to Pancreatic Cancer. First author DOI 10.1016/j.ymthe.2019.02.005↗
  2. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-11-3850↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Zillinger · 1 shared paper, 2019 · strength 0.20
  2. Jonathan Ellermeier · 1 shared paper, 2013 · strength 0.03
  3. Max M. Schnurr · 1 shared paper, 2013 · strength 0.03
  4. Peter Duewell · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.